Due to the complexities of both BMM signaling and BCL6 regulation, additional studies will be needed to determine how these dynamic regulatory pathways affect survival pathways including p53, ATM/ATR, and BCL family proteins within ALL cells and how this may promote resistant disease in the marrow niche. The gene discussed is BCL6; the disease is acute lymphoblastic leukemia.